Ligand Pharmaceuticals to report Q2 2026 results, host conference callPUBT·Jul 23 at 06:00 AMLGND+2.87%
Bank of America Securities Reaffirms Their Buy Rating on Ligand Pharma (LGND)Tip Ranks·Jul 22 at 04:56 AMLGND+2.87%
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $340.00 at Royal Bank Of CanadaMarket Beat·Jul 15 at 11:12 AMLGND+2.87%
Ligand closes acquisition of XOMA Royalty for $39 per share cashPUBT·Jul 14 at 08:01 AMXOMA0.00%LGND+2.87%
3 Overlooked Stocks Positioned for the Next Market RotationMarket Beat·Jul 13 at 07:35 AMLGND+2.87%AFL-1.04%
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $332.00 at Stifel NicolausMarket Beat·Jul 8 at 08:42 AMLGND+2.87%
Ligand CLO, Secretary Andrew Reardon disposes of common shares worth $1.53 millionPUBT·Jul 6 at 04:12 PMLGND+2.87%
Ligand Pharmaceuticals (NASDAQ:LGND) Hits New 1-Year High - Here's WhyMarket Beat·Jun 30 at 02:00 AMLGND+2.87%
Ligand Pharma Completes Major Convertible Notes Financing TransactionTip Ranks·Jun 25 at 04:35 PMLGND+2.87%
Ligand Raises $700M Via 0% Convertible Notes, Adds Note Hedges and $524.34 Strike WarrantsTradingView·Jun 25 at 04:03 PMLGND+2.87%
Ligand closes USD 700 million 0% convertible senior notes offering due 2031PUBT·Jun 25 at 03:01 PMLGND+2.87%
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering | LGND Stock NewsStockTitan·Jun 22 at 07:00 PMLGND+2.87%
